Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kono DH et al. – These findings strongly support the therapeutic targeting of nucleic acid-sensing Toll-like receptor (TLRs) in systemic lupus erythematosus (SLE) and demonstrate the dramatic benefit of simultaneously inhibiting all such TLR family members. These findings also raise the possibility that endosomal TLR (eTLR) signaling may play a critical role in other autoimmune diseases that have anti-nucleic acid Abs.

MethodsResults

Related Articles

Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms
Rheumatology International, 11/10/09    Relevance Score: 66%

Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09    Relevance Score: 65%

B cells in autoimmunity
Arthritis Research & Therapy, 10/29/09    Relevance Score: 65%

Prolactin and Autoimmunity
Clinical Reviews in Allergy and Immunology, 11/18/09    Relevance Score: 64%

Adjuvants and autoimmunity
Lupus, 11/16/09    Relevance Score: 64%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address